Skip to content
Feral Cat LogoGovInfoNow
FDA drug shortage status

Is Riboflavin 5-phosphate Ophthalmic Solution (Photrexa Cross-Linking Kit) in shortage?

Riboflavin 5-phosphate Ophthalmic Solution is listed by FDA as being discontinued by at least one maker (updated Jan 20, 2026).

Being discontinuedFDA status
1packages listed
0unavailable

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)
    Glaukos CorporationBeing discontinuedUpdated Jan 20, 2026Discontinued Jan 20, 2026

    Discontinuing manufacture of the product as of July 2026.

    Maker contact: 949-367-9600

Riboflavin 5-phosphate Ophthalmic Solution shortage questions

Is Riboflavin 5-phosphate Ophthalmic Solution (Photrexa Cross-Linking Kit) in shortage?

Riboflavin 5-phosphate Ophthalmic Solution is listed by FDA as being discontinued by at least one maker (updated Jan 20, 2026).

What should I do if I can’t get Riboflavin 5-phosphate Ophthalmic Solution?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.